Patterns of synthetic cannabinoid use in Australia
MetadataShow full item record
Introduction and Aims. To assess the demographic profile, use patterns, market characteristics, reasons for first use and self-reported harms associated with use of synthetic cannabinoids in Australia. Design and Methods. An online questionnaire was administered to a purposive sample of 316 Australian synthetic cannabinoid users [96% cannabis users,77% male, median age 27 years, interquartile range (IQR) 23–34] who self-reported demographic and drug use characteristics. Results. The median duration of synthetic cannabinoid use was 6 months (IQR 2–10),35% reported use weekly or more often and 7% reported daily use. Reasons for first use included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic effects (9%), non-detection in standard drug screening assays (8%) and to aid the reduction or cessation of cannabis use (5%). Users reported buying a median of 3 g (IQR 3–6) and paying a median of AU$60 (IQR 37–90). Most (68%) reported at least one side-effect during their last session of use, including decreased motor co-ordination (39%), fast or irregular heartbeat (33%), dissociation (22%), dizziness (20%), paranoia (18%) and psychosis (4%). 4 respondents reported seeking help. A greater number of side-effects were reported by males, those aged 18–25 years, water pipe (‘bong’) users and concurrent alcohol drinkers. Discussion and Conclusions. The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non-detection in drug testing and to reduce their cannabis use.Harms were widely reported yet help-seeking was minimal. Inclusion of questions regarding synthetic cannabinoids in household surveys is warranted.
Showing items related by title, author, creator and subject.
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sampleWinstock, A.; Barratt, Monica (2013)Background: The last decade has seen the appearance of myriad novel psychoactive substances with diverse effect profiles. Synthetic cannabinoids are among the most recently identified but least researched of these substances. ...
Sutherland, R.; Bruno, R.; Peacock, A.; Lenton, Simon; Matthews, A.; Salom, C.; Dietze, P.; Butler, K.; Burns, L.; Barratt, Monica (2017)Background Examine the motivations for new psychoactive substance (NPS) use amongst a sample of regular psychostimulant users (RPU) in Australia, and determine whether motivations differ across substances. Method Data ...
Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harmBright, Stephen; Bishop, Brian; Kane, Robert; Marsh, Alison; Barratt, Monica (2013)Background Having first appeared in Europe, synthetic cannabis emerged as a drug of concern in Australia during 2011. Kronic is the most well-known brand of synthetic cannabis in Australia and received significant media ...